Cargando…

Dualmarker: a flexible toolset for exploratory analysis of combinatorial dual biomarkers for clinical efficacy

BACKGROUND: An increasing number of clinical trials require biomarker-driven patient stratification, especially for revolutionary immune checkpoint blockade therapy. Due to the complicated interaction between a tumor and its microenvironment, single biomarkers, such as PDL1 protein level, tumor muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaopeng, Huang, Ruiqi, Wu, Xikun, Zhang, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972341/
https://www.ncbi.nlm.nih.gov/pubmed/33731020
http://dx.doi.org/10.1186/s12859-021-04050-6